Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YER190C-A (YER190C-A)
Product Specs
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Note: All proteins are shipped with standard blue ice packs unless dry ice is specifically requested in advance. Additional fees apply for dry ice shipping.
The tag type will be determined during the production process. If you require a specific tag, please inform us, and we will prioritize its development.
Target Background
STRING: 4932.YPL283W-A
Q&A
What initial approaches should be used to characterize the function of YER190C-A?
Initial characterization should employ a multi-faceted approach combining computational prediction with experimental validation. Begin with sequence homology analysis using BLAST and protein family databases to identify potential conserved domains. Follow with subcellular localization studies using fluorescent protein tagging (GFP/RFP) to determine the protein's location within the cell. Complementing these approaches, gene expression profiling under various conditions (nutrient limitation, stress, cell cycle phases) can provide functional insights. For targeted disruption, utilize CRISPR-Cas9 or traditional homologous recombination approaches to generate knockout strains, followed by phenotypic characterization including growth rate measurement, morphological analysis, and stress response evaluation .
How can I confirm whether YER190C-A interacts with other proteins in the yeast proteome?
To identify protein-protein interactions for YER190C-A, implement a multi-assay validation strategy. Begin with yeast two-hybrid screening using YER190C-A as bait against a comprehensive S. cerevisiae prey library. Confirm positive interactions using co-immunoprecipitation with epitope-tagged versions of YER190C-A. For higher confidence results, employ proximity-dependent biotinylation (BioID) or APEX2 techniques, which capture transient interactions in the native cellular environment. Finally, validate physiologically relevant interactions using bimolecular fluorescence complementation (BiFC) to visualize interaction locations within living cells .
What expression systems are most effective for producing recombinant YER190C-A for biochemical studies?
For biochemical characterization of YER190C-A, consider both homologous and heterologous expression systems based on your experimental needs:
How can I determine if YER190C-A participates in specific metabolic or signaling pathways?
To determine pathway involvement, implement a systematic investigation combining genetic and biochemical approaches. First, conduct synthetic genetic array (SGA) analysis by crossing YER190C-A deletion strains with genome-wide deletion libraries to identify genetic interactions that suggest shared pathways. Follow with metabolomic profiling comparing wild-type and YER190C-A deletion strains using LC-MS/MS to identify metabolite level changes. To identify potential regulatory relationships, perform phosphoproteomic analysis to detect changes in signaling cascade components. Finally, utilize chromatin immunoprecipitation followed by sequencing (ChIP-seq) if YER190C-A shows nuclear localization to identify DNA binding sites and potential transcriptional regulatory functions .
What approaches can determine if YER190C-A has enzymatic activity?
To investigate potential enzymatic functions of YER190C-A, implement a systematic biochemical characterization workflow. Begin with in silico analysis using tools like PROSITE and Pfam to predict functional domains that suggest catalytic activity. Purify the recombinant protein with minimal tags to avoid interference with active sites. Screen for enzymatic activity using substrate libraries covering major enzyme classes (hydrolases, transferases, oxidoreductases, etc.). For positive hits, conduct detailed kinetic analysis determining Km, Vmax, and optimal reaction conditions. If conventional approaches yield no results, consider high-throughput substrate screening using metabolite arrays or activity-based protein profiling (ABPP) with chemical probes designed to react with specific enzyme families.
How can I develop a functional genomic screen to identify genetic interactions with YER190C-A?
Developing a comprehensive genetic interaction screen for YER190C-A requires a structured approach focused on phenotypic outcomes. Construct a query strain where YER190C-A is either deleted or conditionally expressed. Cross this query strain with the yeast deletion collection (~4,800 non-essential gene deletions) using synthetic genetic array (SGA) methodology to generate double mutants. Score growth phenotypes systematically using automated colony size measurement to identify synthetic lethal, sick, or suppressor interactions. For essential genes, use decreased abundance by mRNA perturbation (DAmP) alleles or temperature-sensitive mutants. Analyze the resulting interaction network using clustering algorithms to identify functional modules. This approach revealed protein translocation capabilities when bacterial proteins were expressed in yeast, suggesting similar screens could illuminate YER190C-A function .
What methods are most effective for structural characterization of YER190C-A?
For structural characterization of YER190C-A, implement a multi-technique approach based on protein size, solubility, and crystallization propensity:
| Technique | Resolution | Sample Requirements | Advantages | Limitations |
|---|---|---|---|---|
| X-ray crystallography | Atomic (1-3Å) | Crystallizable protein (mg quantities) | Highest resolution, detailed atomic structure | Requires crystallization |
| Cryo-electron microscopy | Near-atomic (2-4Å) | Purified protein (μg quantities) | Works with larger proteins/complexes | Complex data processing |
| NMR spectroscopy | Atomic (solution) | Isotope-labeled protein (mg quantities) | Dynamic information, solution state | Size limitation (~30kDa) |
| Small-angle X-ray scattering | Low (10-20Å) | Monodisperse samples | Works in solution, minimal sample prep | Low resolution, shape only |
| Begin with secondary structure prediction software followed by circular dichroism spectroscopy to validate predictions. For YER190C-A, which is likely a small protein, prioritize NMR if the protein is soluble or X-ray crystallography if it crystallizes readily. Consider using homology modeling based on structural homologs identified through HHpred if experimental structures prove challenging. |
How can I identify critical functional residues in YER190C-A?
To identify functional residues in YER190C-A, implement a systematic mutagenesis strategy combined with evolutionary analysis. First, perform multiple sequence alignment with orthologs from related yeast species to identify conserved residues, which often indicate functional importance. Conduct evolutionary rate analysis to identify positions under selective pressure. Design an alanine scanning mutagenesis library targeting conserved residues and evaluate functional consequences using complementation assays in YER190C-A deletion strains. For more precision, employ site-directed mutagenesis on specific residues predicted to be functionally important based on structural models or conserved motifs. Apply deep mutational scanning by generating comprehensive codon substitution libraries followed by functional selection and next-generation sequencing to create a comprehensive map of residue importance across the entire protein sequence.
Under what conditions is YER190C-A expression most significantly altered?
To comprehensively characterize YER190C-A expression patterns, implement a systematic profiling approach across diverse physiological conditions. Construct reporter strains with YER190C-A promoter driving luciferase or fluorescent protein expression to enable real-time monitoring. Screen expression changes across a matrix of conditions including:
How does YER190C-A deletion affect cellular responses to various stressors?
To determine the role of YER190C-A in stress responses, conduct a comparative phenotypic analysis between wild-type and knockout strains across multiple stress conditions. Measure growth characteristics using both plate-based assays (spot dilutions) and liquid culture growth curves with automated monitoring systems. Assess cellular morphology using microscopy and quantitative image analysis. Measure key physiological parameters including reactive oxygen species levels, mitochondrial membrane potential, and ATP content. Analyze transcriptional responses using RNA-seq to identify differentially regulated pathways in the absence of YER190C-A. Focus particularly on oxidative stress, nutrient limitation, and temperature shifts, as yeast screens have demonstrated these conditions often reveal phenotypes for uncharacterized proteins. Quantify stress-specific metabolites using targeted metabolomics to identify biochemical pathways affected by YER190C-A deletion .
What high-throughput screening methods can help determine YER190C-A function?
High-throughput screening approaches can significantly accelerate functional characterization of YER190C-A. Implement a multi-platform screen combining genetic, chemical, and physical interaction methods:
How can CRISPR-Cas9 technology be optimized for studying YER190C-A in S. cerevisiae?
To optimize CRISPR-Cas9 editing for YER190C-A functional studies, implement a systematic protocol tailored to yeast genetics. Design at least three guide RNAs targeting different regions of YER190C-A using yeast-optimized scoring algorithms that account for chromatin accessibility and PAM site availability. When constructing expression vectors, use RNA polymerase III promoters (SNR52) for guide RNA expression and a strong constitutive promoter (TEF1) for Cas9. For precise modifications, provide repair templates with 40-60bp homology arms flanking the desired edit. To increase editing efficiency, synchronize cells in G2/M phase using nocodazole treatment before transformation, as DNA repair by homologous recombination is most active during this cell cycle phase. For complex modifications, consider a two-step approach with temporary selection markers. Validate all edits by sequencing and assess potential off-target effects using whole-genome sequencing of edited strains compared to parental lines .
How should I integrate transcriptomic, proteomic, and metabolomic data to understand YER190C-A function?
To comprehensively integrate multi-omics data for YER190C-A functional characterization, implement a structured analytical pipeline. Begin with independent analysis of each data type: differential expression analysis for transcriptomics, protein abundance changes for proteomics, and metabolite concentration differences for metabolomics, all comparing YER190C-A deletion to wild-type strains. Apply pathway enrichment analysis to each dataset separately using tools like KEGG and GO term enrichment. For integration, implement coexpression network analysis using weighted gene correlation network analysis (WGCNA) to identify modules of co-regulated genes, proteins, and metabolites. Use Bayesian network modeling to infer causal relationships between different molecular entities. Apply dimensionality reduction techniques like multi-omics factor analysis (MOFA) to identify major sources of variation across datasets. Visualize integrated networks using Cytoscape with multi-omics visualization plugins. This integrated approach will reveal functional relationships that may not be apparent from any single data type and provide a systems-level understanding of YER190C-A's role in cellular processes .
What bioinformatic approaches can predict potential functions of YER190C-A based on sequence and structure?
To predict YER190C-A function using computational approaches, implement a hierarchical prediction strategy combining sequence, structure, and network-based methods. Begin with sensitive sequence analysis using position-specific iterative BLAST (PSI-BLAST) and hidden Markov models (HMMer) to detect remote homologs. Apply protein structure prediction using AlphaFold2 or RoseTTAFold to generate high-confidence structural models. Use structural alignment tools like DALI and TM-align to identify proteins with similar folds despite low sequence identity. Predict functional sites using ConSurf to identify evolutionarily conserved residues and SiteMap to identify potential binding pockets. For network-based prediction, implement guilt-by-association methods using functional association networks from STRING database. Apply machine learning approaches that integrate diverse features (expression patterns, genetic interactions, protein-protein interactions) to predict function based on proteins with similar profiles. Finally, use phylogenetic profiling to identify proteins with similar evolutionary patterns across species, suggesting functional relationships .
How can YER190C-A characterization contribute to understanding related proteins in pathogenic yeasts?
Characterizing YER190C-A in S. cerevisiae provides valuable insights applicable to pathogenic fungi through comparative functional genomics. Identify orthologs in pathogenic species such as Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus using reciprocal BLAST and synteny analysis. Construct ortholog deletion strains in these pathogens and perform comparative phenotypic analysis across infection-relevant conditions (serum exposure, pH shifts, immune cell interaction). If YER190C-A proves essential in pathogens but not in S. cerevisiae, it represents a potential antifungal target. Apply knowledge from S. cerevisiae screens to design targeted experiments in pathogenic species, focusing on conditions where YER190C-A shows significant phenotypes. If structural data is available, use it to inform potential inhibitor design for pathogen-specific orthologs. The S. cerevisiae functional characterization can serve as a blueprint for understanding related proteins in pathogens, potentially leading to new therapeutic strategies for fungal infections .
How can YER190C-A research inform therapeutic vaccine development using S. cerevisiae as a delivery platform?
Characterization of YER190C-A can substantially enhance the development of S. cerevisiae-based therapeutic vaccines. S. cerevisiae-based vaccines represent an ideal therapeutic approach due to their ability to stimulate tumor- or viral-specific CD4+ and CD8+ T-cell responses capable of reducing disease burden . Understanding YER190C-A's function, particularly its potential role in cell wall organization, stress response, or protein processing, could optimize vaccine design in several ways:
